Lab
Quest Diagnostics Clinical Laboratories INC
Quest Diagnostics Clinical Laboratories INC was paid $186K by Medicaid between Jul 2019 and Nov 2024, across 83 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoQUEST DIAGNOSTICS CLINICAL LABORATORIES INC
ROANOKE, VA 24014
ROANOKE, VA 24014
33aNPI1851959928assigned 06/03/2019
33bProvider typeClinical Medical Laboratory
28Total paid$186K
24GClaims64,460
24DCodes billed83
24AFirst – last monthJul 2019 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Virginia
Rank by total paid#33 of 78
Median peer was paid$37K
This provider vs. median5.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 16,996 | $28K | |
| 2020 | 11,744 | $31K | |
| 2021 | 5,548 | $23K | |
| 2022 | 5,936 | $23K | |
| 2023 | 5,825 | $32K | |
| 2024incomplete | 18,411 | $48K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 7,554 | 6,804 | $26K |
| 80061 | Lipid panel | 9.5% | 4,410 | 4,137 | $18K |
| 86803 | 9.4% | 1,609 | 1,525 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | 9.3% | 3,860 | 3,566 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 7.4% | 3,665 | 3,369 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7.3% | 5,800 | 5,058 | $14K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.4% | 3,009 | 2,822 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.3% | 4,500 | 3,548 | $8K |
| 87340 | 4.3% | 956 | 911 | $8K | |
| 85027 | 4.0% | 4,120 | 3,576 | $7K | |
| 86762 | 2.4% | 559 | 531 | $4K | |
| 86850 | 2.1% | 1,093 | 1,035 | $4K |
71 more codes
| 82607 | 1.6% | 843 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.6% | 286 | $3K |
| 87186 | 1.6% | 1,248 | $3K | |
| 80050 | General health panel | 1.2% | 533 | $2K |
| 83735 | 1.2% | 1,170 | $2K | |
| 84439 | 1.1% | 705 | $2K | |
| 86900 | 1.0% | 737 | $2K | |
| 86901 | 1.0% | 737 | $2K | |
| 87077 | 1.0% | 941 | $2K | |
| 82570 | <1% | 805 | $1K | |
| 82728 | <1% | 329 | $1K | |
| 87660 | <1% | 217 | $1K | |
| 87510 | <1% | 217 | $1K | |
| 87480 | <1% | 217 | $1K | |
| 80076 | <1% | 358 | $1K | |
| 83880 | <1% | 215 | $878.60 | |
| 83540 | <1% | 386 | $684.41 | |
| 86140 | <1% | 424 | $666.52 | |
| 82746 | <1% | 220 | $662.63 | |
| 81001 | <1% | 1,414 | $605.09 | |
| 87070 | <1% | 455 | $568.48 | |
| 82043 | <1% | 512 | $477.16 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 75 | $456.17 |
| 87081 | <1% | 141 | $445.49 | |
| 85610 | <1% | 584 | $433.17 | |
| 80074 | <1% | 33 | $423.44 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 74 | $421.08 |
| 87088 | <1% | 226 | $409.10 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 19 | $352.00 |
| 85652 | <1% | 452 | $347.85 | |
| 80164 | <1% | 223 | $299.25 | |
| 83550 | <1% | 167 | $281.61 | |
| 83970 | <1% | 129 | $271.97 | |
| 84156 | <1% | 167 | $270.68 | |
| 84550 | <1% | 235 | $265.02 | |
| 86592 | <1% | 93 | $259.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,202 | $238.48 |
| 80348 | <1% | 51 | $237.69 | |
| 82950 | <1% | 78 | $219.40 | |
| 80361 | <1% | 29 | $128.40 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 65 | $125.56 |
| 84436 | <1% | 109 | $124.33 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $121.65 |
| 84480 | <1% | 69 | $121.18 | |
| 86706 | <1% | 59 | $107.40 | |
| 84702 | <1% | 37 | $100.30 | |
| 87205 | <1% | 103 | $86.41 | |
| 80069 | <1% | 114 | $57.21 | |
| 87075 | <1% | 41 | $52.68 | |
| 82105 | <1% | 13 | $50.31 | |
| 87147 | <1% | 76 | $41.44 | |
| 83615 | <1% | 24 | $36.24 | |
| 86160 | <1% | 14 | $35.12 | |
| 84479 | <1% | 40 | $34.48 | |
| 82565 | <1% | 22 | $25.60 | |
| 81003 | <1% | 74 | $21.13 | |
| 84100 | <1% | 66 | $20.55 | |
| 84153 | <1% | 55 | $18.39 | |
| 83690 | <1% | 36 | $13.78 | |
| 82550 | <1% | 29 | $13.02 | |
| 85018 | <1% | 26 | $11.14 | |
| 87045 | <1% | 19 | $3.64 | |
| 87046 | <1% | 22 | $2.02 | |
| 87338 | 0% | 15 | $0.00 | |
| 87177 | 0% | 14 | $0.00 | |
| 85045 | 0% | 31 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 13 | $0.00 |
| 82977 | 0% | 18 | $0.00 | |
| 87899 | 0% | 18 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 131 | $0.00 |
| 82670 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOWLES, CHARLES (VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.